Nicotine Delivery From Novel Non-Tobacco Electronic System in Smokers
- Conditions
- Healthy SubjectCigarette SmokerCurrent Smoker
- Interventions
- Other: Electronic CigaretteOther: Laboratory Biomarker AnalysisOther: Pharmacological StudyOther: Questionnaire Administration
- First Posted Date
- 2015-10-15
- Last Posted Date
- 2018-06-12
- Lead Sponsor
- Roswell Park Cancer Institute
- Target Recruit Count
- 36
- Registration Number
- NCT02575885
- Locations
- πΊπΈ
Roswell Park Cancer Institute, Buffalo, New York, United States
Pan FGFR Kinase Inhibitor BGJ398 and Combination Chemotherapy in Treating Patients With Untreated Metastatic Pancreatic Cancer
- Conditions
- Colon AdenocarcinomaMetastatic Pancreatic AdenocarcinomaPancreatic AdenocarcinomaPancreatic Ductal AdenocarcinomaRectal AdenocarcinomaStage III Pancreatic CancerStage IVA Rectal CancerStage IIIA Colon CancerStage IIIB Colon CancerStage IIIC Colon Cancer
- Interventions
- Other: Laboratory Biomarker AnalysisDrug: pan FGFR Kinase Inhibitor BGJ398Other: Pharmacological Study
- First Posted Date
- 2015-10-14
- Last Posted Date
- 2016-05-20
- Lead Sponsor
- Roswell Park Cancer Institute
- Registration Number
- NCT02575508
- Locations
- πΊπΈ
Roswell Park Cancer Institute, Buffalo, New York, United States
Gabapentin, Methadone Hydrochloride, and Oxycodone Hydrochloride in Improving Quality of Life in Patients With Stage II-IV Head and Neck Cancer During Chemoradiation
- Conditions
- StomatitisHead and Neck Squamous Cell CarcinomaPain
- Interventions
- Other: Quality-of-Life AssessmentOther: Questionnaire Administration
- First Posted Date
- 2015-08-25
- Last Posted Date
- 2022-07-25
- Lead Sponsor
- Roswell Park Cancer Institute
- Target Recruit Count
- 60
- Registration Number
- NCT02531906
- Locations
- πΊπΈ
Roswell Park Cancer Institute, Buffalo, New York, United States
Acupuncture-Like Transcutaneous Electrical Nerve Stimulation in Treating Radiation-Induced Xerostomia in Patients With Head and Neck Cancer
- Conditions
- Head and Neck CarcinomaXerostomia
- Interventions
- Other: Quality-of-Life AssessmentProcedure: Transcutaneous Acupoint Electrical Stimulation
- First Posted Date
- 2015-06-17
- Last Posted Date
- 2022-07-25
- Lead Sponsor
- Roswell Park Cancer Institute
- Target Recruit Count
- 30
- Registration Number
- NCT02474095
- Locations
- πΊπΈ
Roswell Park Cancer Institute, Buffalo, New York, United States
SurVaxM Vaccine Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma
- Conditions
- GlioblastomaGliosarcoma
- Interventions
- Other: Laboratory Biomarker Analysis
- First Posted Date
- 2015-05-28
- Last Posted Date
- 2025-03-03
- Lead Sponsor
- Roswell Park Cancer Institute
- Target Recruit Count
- 66
- Registration Number
- NCT02455557
- Locations
- πΊπΈ
Massachusetts General Hospital Cancer Center, Boston, Massachusetts, United States
πΊπΈDana-Farber Harvard Cancer Center, Boston, Massachusetts, United States
πΊπΈBeth Israel Deaconess Medical Center, Boston, Massachusetts, United States
Nintedanib Compared With Placebo in Treating Against Radiation-Induced Pneumonitis in Patients With Non-small Cell Lung Cancer That Cannot Be Removed by Surgery and Are Undergoing Chemoradiation Therapy
- Conditions
- Lung Non-Squamous Non-Small Cell CarcinomaRadiation-Induced PneumonitisStage II Lung Non-Small Cell Cancer AJCC v7Stage IIA Lung Non-Small Cell Carcinoma AJCC v7Stage IIB Lung Non-Small Cell Carcinoma AJCC v7Stage III Lung Non-Small Cell Cancer AJCC v7Stage IIIA Lung Non-Small Cell Cancer AJCC v7Stage IIIB Lung Non-Small Cell Cancer AJCC v7Stage IV Lung Non-Small Cell Cancer AJCC v7
- Interventions
- First Posted Date
- 2015-05-22
- Last Posted Date
- 2020-04-06
- Lead Sponsor
- Roswell Park Cancer Institute
- Target Recruit Count
- 8
- Registration Number
- NCT02452463
- Locations
- πΊπΈ
Roswell Park Cancer Institute, Buffalo, New York, United States
Intensive Locoregional Chemoimmunotherapy for Recurrent Ovarian Cancer Plus Intranodal DC Vaccines
- Conditions
- Neoplasms, OvarianOvary NeoplasmsOvarian CancerCancer of OvaryCancer of the OvaryOvary Cancer
- Interventions
- First Posted Date
- 2015-05-04
- Last Posted Date
- 2025-06-19
- Lead Sponsor
- Roswell Park Cancer Institute
- Target Recruit Count
- 25
- Registration Number
- NCT02432378
- Locations
- πΊπΈ
UPMC CancerCenter at Magee-Womens Hospital of UPMC, Pittsburgh, Pennsylvania, United States
πΊπΈHillman Cancer Center, Pittsburgh, Pennsylvania, United States
Ribociclib and Gemcitabine Hydrochloride in Treating Patients With Advanced Solid Tumors or Lymphoma
- Conditions
- LymphomaSolid Neoplasm
- Interventions
- Other: Laboratory Biomarker AnalysisOther: Pharmacological Study
- First Posted Date
- 2015-04-13
- Last Posted Date
- 2022-07-25
- Lead Sponsor
- Roswell Park Cancer Institute
- Target Recruit Count
- 10
- Registration Number
- NCT02414724
- Locations
- πΊπΈ
Roswell Park Cancer Institute, Buffalo, New York, United States
Nintedanib in Treating Patients With Locally Advanced or Metastatic Neuroendocrine Tumors
- Conditions
- Carcinoid TumorMetastatic Carcinoid TumorNeuroendocrine Neoplasm
- Interventions
- Other: Laboratory Biomarker AnalysisOther: Pharmacological StudyOther: Quality-of-Life Assessment
- First Posted Date
- 2015-03-26
- Last Posted Date
- 2023-12-26
- Lead Sponsor
- Roswell Park Cancer Institute
- Target Recruit Count
- 32
- Registration Number
- NCT02399215
- Locations
- πΊπΈ
Roswell Park Cancer Institute, Buffalo, New York, United States
πΊπΈOhio State University Comprehensive Cancer Center, Columbus, Ohio, United States
Nintedanib and Capecitabine in Treating Patients With Refractory Metastatic Colorectal Cancer
- Conditions
- Rectal AdenocarcinomaRecurrent Colon CarcinomaRecurrent Rectal CarcinomaStage IVA Rectal CancerStage IVA Colon CancerStage IVB Rectal CancerColon AdenocarcinomaStage IVB Colon Cancer
- Interventions
- First Posted Date
- 2015-03-19
- Last Posted Date
- 2021-07-08
- Lead Sponsor
- Roswell Park Cancer Institute
- Target Recruit Count
- 42
- Registration Number
- NCT02393755
- Locations
- πΊπΈ
City of Hope Comprehensive Cancer Center, Duarte, California, United States
πΊπΈRoswell Park Cancer Institute, Buffalo, New York, United States